It’s time to take on your psoriatic arthritis (PsA).
See if the IZAR Clinical Study is right for you.
The IZAR Study for Psoriatic Arthritis - Now Enrolling
Psoriatic arthritis (PsA) is a painful condition that can affect both the joints and skin. PsA is not caused by overuse of joints or aging – rather, it is the result of an overactive immune system and can affect people at any age. Common symptoms of psoriatic arthritis include:
- Pain or swelling in one or more joints
- Joints that are stiff, red or warm to the touch
- Swollen fingers and/or toes that have a sausage-like appearance
- Patches of red, scaly skin (psoriasis)
If you struggle with psoriatic arthritis, you may qualify for the IZAR Clinical Study, now being offered at select medical centers. The IZAR Study is evaluating an injectable investigational medication aimed at alleviating PsA symptoms. If you qualify and choose to join the IZAR Study, you will receive study-related care and monitoring of your PsA condition at no cost. You may also be compensated for your time and travel to attend any required study visits at your local study doctor’s office.
Why Participate?
If you have had psoriatic arthritis (PsA) for at least 6 months and have not had success with other treatments, you may qualify for the IZAR Study. The study is for an injectable investigational medication that is designed to help alleviate symptoms of psoriatic arthritis. If you qualify and choose to join the IZAR study, you will receive:
- Regular assessment of your PsA condition by a medical specialist
- Study-related care and study medication at no cost
- Compensation for time and travel to attend study visits
- The opportunity to help advance psoriatic arthritis research to potentially benefit others suffering from PsA
See If You Qualify
To see if you might qualify for the IZAR Study and to get connected with your local study center to learn more, please take the questionnaire below.
Patient_Website _V1_21Mar2025